Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2015 08:30 ET | Source: Relypsa, Inc.

Relypsa to Present at Two Upcoming Conferences

REDWOOD CITY, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) today announced that the company will present at two upcoming investor conferences in September 2015. Kristine...
August 18, 2015 16:30 ET | Source: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 17, 2015, the compensation committee of the company's...
August 10, 2015 16:06 ET | Source: Relypsa, Inc.

Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States

REDWOOD CITY, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced it has entered a two-year detailing agreement with Sanofi for Patiromer...
August 10, 2015 16:05 ET | Source: Relypsa, Inc.

Relypsa and Vifor Fresenius Medical Care Renal Pharma Enter Into Partnership to Commercialize Patiromer FOS in Europe and Additional Territories

REDWOOD CITY, Calif., and ST. GALLEN, Switzerland, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, and Vifor Fresenius Medical Care Renal Pharma Ltd....
August 06, 2015 16:15 ET | Source: Relypsa, Inc.

Relypsa Announces Second Quarter 2015 Financial Results

REDWOOD CITY, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today reported financial results for the quarter ended June 30, 2015. Net loss for the...
August 05, 2015 08:30 ET | Source: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on August 3, 2015, the compensation committee of the company's...
August 03, 2015 08:30 ET | Source: Relypsa, Inc.

Relypsa to Present at the 2015 Wedbush PacGrow Healthcare Conference

REDWOOD CITY, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), today announced that John A. Orwin, president and chief executive officer, will present at the 2015 Wedbush PacGrow...
July 24, 2015 08:30 ET | Source: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., July 24, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 15, 2015, the compensation committee of the company's...
July 14, 2015 11:48 ET | Source: Relypsa, Inc.

JAMA Publishes Long-Term Safety and Efficacy Results of Trial With Relypsa's Patiromer FOS Over One Year

Patiromer FOS significantly decreased blood potassium levels in patients with chronic kidney disease and hyperkalemia at four weeks (primary endpoint) Potassium levels were maintained at...
July 02, 2015 08:30 ET | Source: Relypsa, Inc.

Relypsa Announces New Employment Inducement Grants

REDWOOD CITY, Calif., July 2, 2015 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that on July 1, 2015, the compensation committee of the company's board...